Hydroxyurea 100 MG/ML Oral Solution [Xromi] — RxCUI 2696079
RxNorm drug concept · Semantic branded drug
RxCUI 2696079
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2696079
Official nameHydroxyurea 100 MG/ML Oral Solution [Xromi]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXromi 100 MG per 1 mL Oral Solution; Xromi 100 MG in 1 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)10,105 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Hydroxyurea: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's actually both, depending on the specific product. Droxia, Siklos, and Xromi are each approved to reduce the painful crises and blood transfusion needs in sickle cell anemia. H...
- What exactly is hydroxyurea used for — is it a cancer drug or a sickle cell drug?
- Very regularly — typically every two weeks while your dose is being adjusted. Hydroxyurea can lower your white blood cell and platelet counts, so monitoring is built into the treat...
- How often will I need blood tests while I'm on this medication?
🕸️ Concept Web — How Hydroxyurea 100 MG/ML Oral Solution [Xromi] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Hydroxyurea 100 MG/ML Oral Solution [Xromi]
RxCUI 2696079 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Hydroxyurea
5552IN
-
Hydroxyurea
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xromi
2696074BN
-
Xromi
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Hydroxyurea Oral Solution
2682740SCDF -
Hydroxyurea Oral Liquid Product
2682739SCDG -
Hydroxyurea Oral Product
1160113SCDG -
Hydroxyurea Oral Solution [Xromi]
2696078SBDF -
Xromi Oral Liquid Product
2696077SBDG -
Xromi Oral Product
2696076SBDG -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Hydroxyurea Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Hydroxyurea 100 MG/ML Oral Solution
2682741SCD -
Hydroxyurea 100 MG/ML
2682738SCDC -
Hydroxyurea 100 MG/ML [Xromi]
2696075SBDC
-
Hydroxyurea 100 MG/ML Oral Solution
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Hydroxyurea 100 MG/ML Oral Solution
SCD · 2682741 -
Hydroxyurea 100 MG/ML
SCDC · 2682738 -
Hydroxyurea Oral Solution
SCDF · 2682740 -
Hydroxyurea Oral Liquid Product
SCDG · 2682739 -
Hydroxyurea Oral Product
SCDG · 1160113
Brand-Name Concepts
-
Hydroxyurea 100 MG/ML [Xromi]
SBDC · 2696075 -
Hydroxyurea Oral Solution [Xromi]
SBDF · 2696078 -
Xromi Oral Liquid Product
SBDG · 2696077 -
Xromi Oral Product
SBDG · 2696076 -
Xromi
BN · 2696074
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2696079 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 62484-0015-05 | 1 BOTTLE in 1 CARTON (62484-0015-5) / 148 mL in 1 BOTTLE (6... | XROMI | Nova Laboratories, Ltd. | 2024-04-04 |
Observed labelers:
Nova Laboratories, Ltd. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$4.9525
Range $4.9525–$4.9525
· middle 50% $4.9525–$4.9525
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.